Aurinia Pharmaceuticals Inc.AUPHNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
4.94%
↓ 100% below average
Average (39q)
4395.89%
Historical baseline
Range
High:172417.24%
Low:-98.17%
Volatility
3924.5%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 4.94% |
| Q2 2025 | 12.08% |
| Q1 2025 | 4.34% |
| Q4 2024 | -11.66% |
| Q3 2024 | 18.50% |
| Q2 2024 | 13.70% |
| Q1 2024 | 11.55% |
| Q4 2023 | -17.28% |
| Q3 2023 | 31.38% |
| Q2 2023 | 20.59% |
| Q1 2023 | 21.01% |
| Q4 2022 | -49.02% |
| Q3 2022 | 97.86% |
| Q2 2022 | 30.36% |
| Q1 2022 | -7.60% |
| Q4 2021 | 59.57% |
| Q3 2021 | 121.56% |
| Q2 2021 | 624.29% |
| Q1 2021 | -98.17% |
| Q4 2020 | 172417.24% |
| Q3 2020 | 0.00% |
| Q2 2020 | -3.33% |
| Q1 2020 | 3.45% |
| Q4 2019 | -87.39% |
| Q3 2019 | 693.10% |
| Q2 2019 | -3.33% |
| Q1 2019 | 3.45% |
| Q4 2018 | -92.27% |
| Q3 2018 | 1193.10% |
| Q2 2018 | -3.33% |
| Q1 2018 | -3.23% |
| Q4 2017 | 6.90% |
| Q3 2017 | -91.19% |
| Q2 2017 | 961.29% |
| Q1 2017 | 3.33% |
| Q4 2016 | -3.23% |
| Q3 2016 | -43.64% |
| Q2 2016 | -3.51% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |